Literature DB >> 7647019

Development of resistance to activated protein C during pregnancy.

A M Cumming1, R C Tait, S Fildes, A Yoong, S Keeney, C R Hay.   

Abstract

We measured activated protein C (APC) anticoagulant activity in 20 healthy women at 14-20, 28 and 36 weeks gestation, and at 1 d post-partum. Significant reductions in the mean APC sensitivity ratio (APC-SR) were observed at all stages of pregnancy studied compared with the mean APC-SR obtained for baseline measurements carried out at > 8 weeks post-partum. APC resistance was seen in 8/19 (42%) and in 11/20 (55%) women at 14-20 and 28 weeks gestation respectively. The development of resistance to APC may contribute to the increased risk of thrombosis during pregnancy.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7647019     DOI： 10.1111/j.1365-2141.1995.tb05610.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  17 in total

1.  The relationship between activated protein C-resistance and recurrent abortion.

Authors:  W Dong; W Wei; M Lin
Journal:  J Tongji Med Univ       Date:  2000

Review 2.  Issues concerning the laboratory investigation of inherited thrombophilia.

Authors:  Armando Tripodi
Journal:  Mol Diagn       Date:  2005

3.  The Normal anticoagulant system and risk of placental abruption: protein C, protein S and resistance to activated protein C.

Authors:  Cande V Ananth; Carl A Nath; Claire Philipp
Journal:  J Matern Fetal Neonatal Med       Date:  2010-03-24

4.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

5.  Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case-control study in Indian population.

Authors:  Amit Sharma; Teena Bhakuni; Ravi Ranjan; Ravi Kumar; Kamal Kishor; Vineet Kumar Kamal; Manoranjan Mahapatra; Mohamad Aman Jairajpuri; Renu Saxena
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

Review 6.  Management of inherited thrombophilia in pregnancy.

Authors:  Laura Ormesher; Louise Simcox; Clare Tower; Ian A Greer
Journal:  Womens Health (Lond)       Date:  2016-07

7.  Hereditary thrombophilic risk factors for recurrent pregnancy loss.

Authors:  Nadja Bogdanova; Arseni Markoff
Journal:  J Community Genet       Date:  2010-06-11

8.  Development of a rapid DNA screening procedure for the Factor V Leiden mutation.

Authors:  G A Scobie; S T Ho; G Dolan; N A Kalsheker
Journal:  Clin Mol Pathol       Date:  1996-12

9.  The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Samuel S Edwin; Chia-Ling Nhan-Chang; Nandor Gabor Than; Chong Jai Kim; Sun Kwon Kim; Lami Yeo; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-23

Review 10.  Ischemic stroke and cerebral venous sinus thrombosis in pregnancy.

Authors:  Hannah J Roeder; Jean Rodriguez Lopez; Eliza C Miller
Journal:  Handb Clin Neurol       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.